New IPOs and commencement of listings; Lode Resources, Polymetals, Codrus Minerals and Argenica Therapeutics

/

Hi IPOWatchers!

It’s been a busy week for IPOs once again. Over the past 8 days 6 companies have listed on the ASX following successful IPOs.

We’ve also seen several new prospectuses lodged with 4 new IPOs to keep an eye on!

First up, let’s talk about the newest IPOs; Lode Resources, Polymetals, Codrus Minerals and Argenica Therapeutics.

Lode Resources Limited is a junior copper, gold and silver explorer with the aim of creating shareholder value through the exploration and development of high-quality deposits in the New England Fold Belt in NSW.

Lode own 6 projects in the New England Fold Belt, all of which are 100% owned and already have significant preliminary surface work done including geophysics and/or geochemistry. The company‘s strategy is to:

  1. Systematically explore and develop the Company’s Tenements in the New England Fold Belt;

  2. Target large-scale gold, silver and copper mineral systems;

  3. Use modern exploration methods and best practices in cost effective programs; and

  4. Advance discoveries to the development stage.

Lode Resources is aiming to raise between $5,000,000 and $7,500,000 at an issue price of $0.20. The offer is open right now and will close in 4 days on the 17th of May! The company is expected to list on the 1st of June.

Lode Resources is aiming to raise between $5,000,000 and $7,500,000 at an issue price of $0.20.

Lode Resources is aiming to raise between $5,000,000 and $7,500,000 at an issue price of $0.20.

Also in the resources space is Polymetals Limited.

Polymetals Limited is an Australasian company with a 100% interest in Golden Guinea Resources SARL (Golden Guinea) in Guinea, West Africa.

The company owns two exploration licences within the Siguiri Basin in Guinea, an area that occupies the north-eastern corner of Guinea and hosts several large active gold mining operations and is notable for its widespread gold anomalism. The region is considered prospective and relatively immature from an exploration perspective and produces over 500,000 oz of gold/year.

Polymetals is looking to raise between $5,000,000 and $7,000,000 at an issue price of $0.20. The offer is already open and will close on the 28th of May. Polymetals is expected to list on the ASX on the 15th of June.

Polymetals is looking to raise between $5,000,000 and $7,000,000 at an issue price of $0.20.

Polymetals is looking to raise between $5,000,000 and $7,000,000 at an issue price of $0.20.

Our last resource explorer this week is Codrus Minerals, a company spun out of Blackstone Mineral’s (BSX) non-core gold assets.

Codrus Minerals own 3 projects in the Kalgoorlie and Pilbara regions, and 1 in the mining friendly sate of Oregon, USA. These projects are:

  1. Silver Swan South Project - A Gold and Nickel Prospect 20km Northeast of Kalgoorlie

  2. Red Gate Project - A Gold prospect 140km North of Kalgoorlie

  3. Middle Creek Project - A Gold prospect 185km North of Newman in the East Pilbara Region

  4. Bull Run Project - A Gold prospect in Baker County, Oregon, USA, of which the company has an option to acquire 11 mining claims and 100% interest in an additional 79 claims.

Codrus Minerals is looking to raise $8,000,000 at an issue price of $0.20. The offer opens today and will close on the 3rd of June. Codrus Minerals is expected to list on the ASX on the 23th of June.

Codrus Minerals is looking to raise $8,000,000 at an issue price of $0.20.

Codrus Minerals is looking to raise $8,000,000 at an issue price of $0.20.

Lastly this week we have Argenica Therapeutics Limited, a medical research company looking to develop a treatment for strokes and other acute central nervous system injuries.

The company is undertaking the development and commercialisation of a novel therapeutic, which is based on arginine rich peptides, with the goal to reduce brain damage after stroke and improve patient outcomes. Their lead neuroprotective peptide candidate, ARG007, has been successfully demonstrated to improve outcomes in pre-clinical stroke models and is in the process of being verified for its safety and toxicology before commencing Phase 1 clinical trials in humans.

Argenica Therapeutics is looking to raise $7,000,000 at an issue price of $0.20. The offer opened on the 1st of May and will close on the 21st of May. Argenica Therapeutics is expected to list on the ASX on the 10th of June.

Argenica Therapeutics is looking to raise $7,000,000 at an issue price of $0.20.

Argenica Therapeutics is looking to raise $7,000,000 at an issue price of $0.20.

Also keep an eye out for the 6 new listings this week!

They are:

  1. Black Canyon Limited (BCA)

  2. Qmines Limited (QML)

  3. Nickel X Limited (NKL)

  4. Australasian Gold Limited (A8G)

  5. Global Lithium Resources Limited (GL1)

  6. EP & T Global (EPX)

Have a great Thursday and Friday IPOWatchers and stay tuned for more updates next week.